Factors determining activity and selectivity of antifibrillatory agents on different types of fibrillation.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001285:Atropine / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D003864:Depression, Chemical; D003986:Dibenzocycloheptenes / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009578:Nitrobenzenes / Q000494:pharmacology; D010477:Perfusion; D010627:Phenethylamines / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D051381:Rats; D014326:Tropanes / Q000494:pharmacology; D014693:Ventricular Fibrillation / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D003986:Dibenzocycloheptenes; D004983:Ethanolamines; D009578:Nitrobenzenes; D010627:Phenethylamines; D014326:Tropanes; D001285:Atropine; D011433:Propranolol; D011802:Quinidine; D007545:Isoproterenol; D011188:Potassium; D002118:Calcium; D004837:Epinephrine